oral G2019S-LRRK2 mut.-selective kinase inh.

>70x sel. for ParkinsonÕs mut. over WT, non-BP

from 50k cmpd HTS + homology-based opt.

J. Med. Chem., Nov. 16, 2020

ESCAPE Bio, South San Francisco, CA

EB-42486 (ESCAPE Bio oral G2019S-LRRK2 mutant-selective kinase inhibitor)


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks